AFM
PALI icon

Anson Funds Management’s Palisade Bio PALI Stock Holding History

Anson Funds Management’s Portfolio PALI Stock Details PALI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-1
Closed -$354K – 63
2016
Q2 		$354K Buy
+1
New +$530K 0.07% 52

Other funds holding PALI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
JPCCM
J&P (China) Capital Management Hong Kong, China $586M AUM 82.64% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Anson Funds Management's PALI Position: Q3 2016 in Review

Anson Funds Management sold out of Palisade Bio (PALI) in Q3 2016, closing a stake of 1 share — an estimated $354K sold.

Anson Funds Management first reported a position in PALI in Q2 2016 and held it in 1 quarter. The position peaked at $354K in Q2 2016. 5 funds tracked by Wall St. Rank hold PALI as of Q3 2016.

  • Anson Funds Management reported no remaining Palisade Bio position as of Q3 2016 after selling out during the quarter.
  • Anson Funds Management sold 1 Palisade Bio share in Q3 2016, an estimated $354K.
  • Anson Funds Management first reported a position in Palisade Bio in Q2 2016 and held it in 1 quarter.
  • Anson Funds Management's Palisade Bio position peaked at $354K in Q2 2016.
  • 5 funds tracked by Wall St. Rank held Palisade Bio as of Q3 2016.

Based on Anson Funds Management's 13F filing for Q3 2016, filed 14 Nov 2016.